AVGO vs RPRX · P/E 87, rev $63.89B vs P/E 15, rev $1.30B
Broadcom Inc (AVGO) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock E. Tan.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported AVGO revenue for 2025-11-02 was $63.89B. Net income was $23.13B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the AVGO and RPRX stock pages for the full models.
Not investment advice.